Douglas E. Coltharp, Executive Vice President and Chief Financial Officer of Encompass Health Corp (NYSE:EHC), filed a Form 4 on August 11, 2026, reporting the sale of 18,869 shares of Encompass Health common stock on August 10, 2026.

Key Highlights

  • Shares sold: Coltharp disposed of 18,869 shares of Encompass Health common stock on August 10, 2026.
  • Weighted average price: The shares were sold at a weighted average price of $125.38 per share, with individual transaction prices ranging from $125.03 to $125.69, inclusive.
  • Post-transaction direct ownership: Following the sale, Coltharp directly beneficially owns 50,508 shares.
  • Indirect holdings: Coltharp also holds 27,480 shares indirectly through an irrevocable trust, 125,631 shares indirectly through an irrevocable trust for the benefit of children, and 37,749 shares indirectly through a spouse.
  • Transaction code: The transaction was coded "S," indicating an open-market sale.

Coltharp's Share Sale and Remaining Ownership in Encompass Health

According to the filing, Douglas E. Coltharp, identified as EVP and Chief Financial Officer of Encompass Health Corp, disposed of 18,869 shares of Encompass Health common stock on August 10, 2026. The filing states the per-share price is a weighted average of $125.38, reflecting sales executed in multiple transactions at prices ranging from $125.03 to $125.69, inclusive. The filing notes that Coltharp "undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range."

After the reported transaction, the filing discloses that Coltharp directly beneficially owns 50,508 shares of Encompass Health common stock. In addition to his direct holdings, the filing reports three categories of indirect beneficial ownership: 27,480 shares held by an irrevocable trust, 125,631 shares held by an irrevocable trust for the benefit of children, and 37,749 shares held by a spouse. No derivative securities transactions were reported in Table II of the filing.

The Form 4 was signed by Patrick Darby as attorney-in-fact for Mr. Coltharp and dated August 11, 2026. The date of the earliest reported transaction is listed as August 10, 2026. The filing was made as an individual filing by one reporting person.

What Was Disclosed

The filing discloses that Encompass Health CFO Douglas E. Coltharp sold 18,869 shares of company common stock on August 10, 2026, at a weighted average price of $125.38, retaining direct beneficial ownership of 50,508 shares and additional indirect holdings through trusts and a spouse.